| MYTOKEY ASTELLAS GENE THERAPIES INC.
2046834 18 Jun 2020 | on 02 Nov 2022 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances for treating genetic diseases and disorders and neuromuscular diseases and disorders, namely, X-Linked Myotubular Myopathy, Pompe Disease, Duchenne Muscular Dystrophy, and Myotonic Dystrophy; pharmaceuticals and therapeutic substances for therapeutic purposes in the treatment of genetic diseases and disorders and neuromuscular diseases and disorders, namely, X-Linked Myotubular Myopathy, Pompe Disease, Duchenne Muscular Dystrophy, and Myotonic Dystrophy. | | 
